Univest Securities, LLC Completes $9 Million Direct Offering for China SXT Pharmaceuticals Inc.

Univest Securities, LLC announced the successful closure of a registered direct offering amounting to $9 million for its client  China SXT Pharmaceuticals Inc. (NASDAQ: SXTC), the China-based pharmaceutical company specializing in traditional Chinese medicine. The offering involved the sale of 4,500,000 units at $2.00 per unit, each unit comprised of one Class A ordinary share and one common warrant, with an exercise price of $3.20. The total gross proceeds were $9 million. The offering was made under a shelf registration statement previously filed by the Company and declared effective by the U.S. Securities and Exchange Commission in late 2025. Univest…